Ernexa Therapeutics Inc. Equity Method Investments
Ernexa Therapeutics Inc. (ERNA) had Equity Method Investments of $0 as of 2023-12-31, per its 10-K filed 2024-03-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments and Receivables, Net
us-gaap:EquityMethodInvestments · last filed 2024-03-14
- 2023-12-31: Equity Method Investments $0.00.
- 2023-09-30: Equity Method Investments $0.00.
- 2023-06-30: Equity Method Investments $0.00.
- 2023-03-31: Equity Method Investments $8.00K.
| Period end | Equity Method Investments |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-14 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-11 |
| 2023-03-31 | $8.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $59.00K 10-K · filed 2024-03-14 |
| 2022-09-30 | $68.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $89.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $385.00K 10-Q · filed 2022-07-01 |
| 2021-12-31 | $1.00M 10-K · filed 2023-03-20 |
| 2021-09-30 | $1.00M 10-Q · filed 2021-11-12 |
| 2020-12-31 | $0.00 10-K/A · filed 2022-07-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |